Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1)
-
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1)
structure -
-
CAS No:
14271-04-6
-
Formula:
C31H41N5O5.CH4O3S
-
Chemical Name:
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1)
-
Synonyms:
Ergotaman-3′,6′,18-trione,9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-,(5′α,10α)-,methanesulfonate (1:1);Ergotaman-3′,6′,18-trione,9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-,(5′α,10α)-,monomethanesulfonate (salt);Ergocornine,dihydro-,methanesulfonate;9,10-Dihydroergocornine methanesulfonate
-
CAS No:
Description
ChEBI: The methanesulfonic acid salt of 9,10-dihydroergocornine. It is a component of ergoloid mesylate (codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementi .
Dihydroergocornine mesylate is the methanesulfonic acid salt of 9,10-dihydroergocornine. It is a component of ergoloid mesylate (codergocrine mesilate), a mixture of ergot alkaloid derivatives that is used as a vasodilator and has shown mild benefits in the treatment of vascular dementia. It contains a dihydroergocornine. It derives from an ergocornine.|A 9,10alpha-dihydro derivative of ERGOTAMINE that contains isopropyl sidechains at the 2' and 5' positions of the molecule.
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1) Basic Attributes
659.8
659.299
238-162-1
42RX8KPW29
DTXSID5031428
Safety Information
P201, P202, P281, P308+P313, P405, P501
H361
|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Dihydroergocornine
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1) Use and Manufacturing
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:659.8
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:4
Exact Mass:659.29888458
Monoisotopic Mass:659.29888458
Topological Polar Surface Area:181
Heavy Atom Count:46
Complexity:1210
Defined Atom Stereocenter Count:7
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
5989-77-5
-
Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(phenylmethyl)-, (5′α)-, methanesulfonate (salt)
57884-92-1
-
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-[(1S)-1-methylethyl]-5′-(1-methylpropyl)-, (5′α,10α)-, monomethanesulfonate (salt)
65914-79-6
Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′,5′-bis(1-methylethyl)-, (5′α,10α)-, methanesulfonate (1:1)
SDSRequest for Quotation